4 transcripts
LGND
Earnings call transcript
NASDAQ
2024 Q2
6 Aug 24
revenue outlook. We have made substantial progress to meet or exceed the longer term growth goals that we outlined at our Analyst Day in December of 2023
LGND
Earnings call transcript
NASDAQ
2024 Q1
7 May 24
of Directors with the main goal of making ZellSuvmi commercially available by the end of this year. We believe this product will bring significant improvements
LGND
Earnings call transcript
NASDAQ
2023 Q4
27 Feb 24
positioned to execute against our goals in 2024 and deliver attractive growth and shareholder returns over the long term. .
Thank you, everyone, for joining
LGND
Earnings call transcript
NASDAQ
2023 Q2
8 Aug 23
with the FDA with a PDUFA goal date set of January 5, 2024.
We previously provided capital to Novan for a royalty interest in this program and believe
- Prev
- 1
- Next